Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 37Melanoma 17Prostatic Neoplasms 16Lung Neoplasms 14Neoplasms 13Squamous Cell Carcinoma of Head and Neck 10Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 9Precancerous Conditions 8Lymphoma 8Uterine Cervical Neoplasms 6Pancreatic Neoplasms 6Leukemia 6Esophageal Neoplasms 6Colorectal Neoplasms 6Colonic Neoplasms 6Breast Neoplasms, Male 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Myelodysplastic Syndromes 5Lymphoma, Follicular 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Head and Neck Neoplasms 5Barrett Esophagus 5Adenocarcinoma Of Esophagus 5Salivary Gland Neoplasms 4Recurrence 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4

Interventions

Magnetic Resonance Imaging 2Interferon beta-1b 2Electrocardiography 2Diphenhydramine 2Acetaminophen 2valrubicin 1pembrolizumab 1fludarabine phosphate 1fludarabine 1durvalumab 1dodecyl maltoside 1apaziquone 1aldesleukin 1Tomography, X-Ray Computed 1Respiratory Function Tests 1Proflavine 1Prochlorperazine 1Positron-Emission Tomography 1Ondansetron 1O(6)-codeine methyl ether 1Nicotine Replacement Therapy 1Meperidine 1Mastectomy, Subcutaneous 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1Imiquimod 1Hydroxyzine 1Histamine Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma in Situ × Biopsy × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡